/u/WalkingHorse's posts in /r/LungCancerSupport

Year:

Only show posts with narrations

Study Suggests Need for New Second-Line NSCLC Therapies to Follow Osimertinib

1 upvotes

Mark as read: Add to a list

Liquid Biopsy May Be Helpful for Treatment Decisions in ROS1-Positive NSCLC

1 upvotes

Mark as read: Add to a list

WATCH>>> Dr Bazhenova on Improving Biomarker Development in Lung Cancer

1 upvotes

Mark as read: Add to a list

PD-L1 Expression Remains Primary Guide for NSCLC Treatment Selection in the Absence of Targetable Mutations

1 upvotes

Mark as read: Add to a list

Effects of brain radiotherapy strategies on survival in the era of MRI for patients with limited stage small cell lung cancer | BMC Cancer

1 upvotes

Mark as read: Add to a list

The Glasgow Prognostic Score as a Predictor of Survival After Chemoradiotherapy for Limited-Disease Small Cell Lung Cancer | Oncology

1 upvotes

Mark as read: Add to a list

A cross-sectional analysis of treatment patterns in small-cell lung cancer in five European countries

1 upvotes

Mark as read: Add to a list

Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimens.

1 upvotes

Mark as read: Add to a list

Targeted degradation of KRAS protein in non-small cell lung cancer: Therapeutic strategies using liposomal PROTACs with enhanced cellular uptake and pharmacokinetic profiles

1 upvotes

Mark as read: Add to a list

Evaluation of the prognosis in patients with small-cell lung cancer treated by chemotherapy using tumor shrinkage rate-based radiomics | European Journal of Medical Research

1 upvotes

Mark as read: Add to a list

Title	Upvotes	Mark as read	Favorited	Rating	Add to a list
Study Suggests Need for New Second-Line NSCLC Therapies to Follow Osimertinib	1
Liquid Biopsy May Be Helpful for Treatment Decisions in ROS1-Positive NSCLC	1
WATCH>>> Dr Bazhenova on Improving Biomarker Development in Lung Cancer	1
PD-L1 Expression Remains Primary Guide for NSCLC Treatment Selection in the Absence of Targetable Mutations	1
Effects of brain radiotherapy strategies on survival in the era of MRI for patients with limited stage small cell lung cancer \| BMC Cancer	1
The Glasgow Prognostic Score as a Predictor of Survival After Chemoradiotherapy for Limited-Disease Small Cell Lung Cancer \| Oncology	1
A cross-sectional analysis of treatment patterns in small-cell lung cancer in five European countries	1
Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimens.	1
Targeted degradation of KRAS protein in non-small cell lung cancer: Therapeutic strategies using liposomal PROTACs with enhanced cellular uptake and pharmacokinetic profiles	1
Evaluation of the prognosis in patients with small-cell lung cancer treated by chemotherapy using tumor shrinkage rate-based radiomics \| European Journal of Medical Research	1